The hypothalamic arcuate nucleus is an important target for metabolic and hormonal signals controlling food intake. As demonstrated by c-Fos studies, arcuate neurons are activated in food-deprived mice, whereas refeeding reverses the fastinginduced activation. To evaluate whether an increase in blood glucose has an inhibitory e¡ect on these neurons, we analyzed the c-Fos response to an intraperitoneal glucose injection in fasted mice.
Introduction
Peripheral metabolic cues that signal the availability of energy play a critical role in the control of food intake and energy homeostasis. Glucose, as the primary fuel source for neuronal tissue, has a unique role among these signals. Blood glucose levels change in parallel with the nutritional status. The fluctuation of blood glucose levels is monitored by the brain that then initiates a behavioral response to adjust energy intake [1] . This is supported by the fact that changes in the availability of glucose have profound effects on food intake. Peripheral or central injection of glucose decreases food intake, insulin-induced hypoglycemia or blockade of glucose utilization, for example, by 2-deoxyglucose promotes food intake [1] .
The arcuate nucleus is a hypothalamic key structure area in the control of food intake and energy homeostasis. It is a receptive area for numerous feeding-related signals, and contains neurons expressing orexigenic neuropeptide Y and anorectic, proopiomelanocortin-derived neuropeptides [2] . Gluco-sensitive neurons in the arcuate nucleus, which change their firing rate in correlation with the ambient glucose concentration [3] [4] [5] , are in an important position to influence energy balance.
Interestingly, food deprivation induces c-Fos expression, a marker of neuronal activation, in the arcuate nucleus of mice [6] [7] [8] [9] . This coincides with low circulating glucose levels. The fasting-induced neuronal activation in the arcuate nucleus is reversed rapidly by refeeding [8, 10] , suggesting that the postprandial rise in blood glucose might inhibit arcuate nucleus neurons. To our knowledge, there is at present no in-vivo evidence for such an inhibitory effect of increasing blood glucose levels on arcuate nucleus neurons.
Although c-Fos immunohistochemistry is a well-accepted method to demonstrate stimulatory effects, it is not well suited to investigate directly neuronal inhibition. In previous studies [10] , we therefore used the reversal of fastinginduced c-Fos expression as an approach to characterize the inhibitory action of the anorectic peptide YY on arcuate nucleus neurons in vivo. In these studies administration of peptide YY, similar to refeeding, reduced c-Fos expression in the arcuate nucleus of fasted mice. This was consistent with an inhibitory effect of peptide YY on arcuate nucleus neurons in electrophysiological in-vitro studies [10] .
On the basis of the presumed gluco-sensitive function of the arcuate nucleus, we investigated whether a dose of glucose which reduces food intake also inhibits arcuate nucleus neurons, that is, whether similar to refeeding and peptide YY administration, an intraperitoneal injection of glucose also reverses the fasting-induced c-Fos expression in this nucleus. Such an effect would implicate that a postprandial increase in blood glucose levels acts via the arcuate nucleus as an anorectic signal to oppose excitatory orexigenic stimuli.
Materials
Adult male C57Bl/6N (Charles Rivers, Sulzfeld, Germany) mice (mean body weight o30 g) housed in individual cages in a temperature-controlled room (221C) were used. The mice were kept under a 12-h light/dark cycle (lights off 09.00 am) and had free access to rodent chow (#3430; Kliba Nafag, Kaiseraugst, Switzerland) and water, except as indicated below. All animal procedures were approved by the Veterinary Office of the Canton of Zurich.
In the feeding studies, mice (n¼14) were fasted for 12 h during the light phase. At dark onset they received an intraperitoneal injection of either glucose (2.5 g/kg in saline, 0.1 ml/10 g; n¼7) or saline (0.1 ml/10 g; n¼7). After injection mice were given access to chow. Food intake was measured 0.5, 1 and 2 h later by manually weighing the feeding cups. The amount of food consumed was corrected for spillage. Student's t-test was used to compare cumulative food intake between groups separately at each time point. Po0.05 was considered significant. Results are presented as mean7 SEM.
All animals used in the immunohistochemical studies were handled daily for at least 3 weeks before the experiments, according to the procedure recommended by Ryabinin et al. [11] to reduce handling-induced and injection-induced c-Fos expression. On the day of the experiment, mice (n¼16) were fasted for 12 h during the light phase. At dark onset, two groups of mice received an intraperitoneal injection of either glucose (2.5 g/kg in saline; n¼4) or saline (n¼8) and remained fasted. One additional group of animals was injected with saline and was given access to food after injection (refed group; n¼4). In all mice, brains were removed 2 h after dark onset and processed for c-Fos immunohistochemistry as described previously [12] .
c-Fos expressing arcuate nucleus neurons were identified according to the mouse brain atlas by Hof et al. [13] . Twentyeight corresponding, consecutive sections (20 mm) were manually counted for c-Fos positive arcuate nucleus cells in a blind fashion, in an area within 150 mm from the wall of the third ventricle. The mean value of the cell count/section of an individual animal was used for statistical analyses. Results were compared by one-way analysis of variance, followed by Student-Newman-Keuls post-hoc test. Photomicrographs were taken by a digital camera (AxioCam, Carl Zeiss AG, Feldbach, Switzerland) and the fluorescent images were inverted to greyscale images.
The effect of chow refeeding on blood glucose levels was measured in 12-h fasted mice by tail bleeding. Eight mice were handled daily for at least 2 weeks before the experiments and were made familiar with the blood sampling procedure without an incision of the tail. All animals were food deprived for 12 h during the light phase. At dark onset, a drop of blood was obtained by tail tip amputation from unanesthetized mice and was analyzed by a portable glucometer (Glucometer Elite, Bayer, AG, Zurich, Switzerland). After blood collection, the animals were returned to their home cages and half of the animals (n¼4) were given access to chow. The blood sampling was repeated 10, 20, 30, 45 and 60 min later. The same procedure was repeated in a cross-over design. On a separate occasion, blood glucose was measured in the same mice under ad-libitum feeding conditions at the onset of the dark phase.
In another group of 12-h fasted mice, the effect of an intraperitoneal glucose injection on blood glucose levels was studied in a noncross-over design, but otherwise under the same experimental conditions as described above. After the baseline sample collection at lights off, mice were injected with glucose (2.5 g/kg; n¼7) or an equivalent volume of saline (n¼5). Blood samples were taken at the same time points as above. Mice had no access to food during the experiment. Student's t-test was used to compare blood glucose values between groups separately at each time point.
The portable glucometer used in the blood glucose measurements was validated by comparing its values with the results of a standard automated chemistry analyzer (Cobas Mira, Roche, Rotkrenz, Switzerland) by Student's t-test (n¼2-3 for each measurement). Glucose levels of blood samples of mice and of freshly prepared glucose solutions (2.77, 5.54 and 27.7 mmol/l in saline) were determined by both methods. Over the entire range of glucose concentrations the two methods yielded almost identical results (R¼0.97; Po0.001).
Results
Glucose administration reduced cumulative food intake by 61%, 0.5 h (Po0.01); 53%, 1 h (Po0.001) and 38%, 2 h (Po0.01) after injection when compared with the saline injected controls.
In the immunohistochemical studies, high c-Fos expression was found in the arcuate nucleus of fasted, saline injected mice (3878 cells/section). Refeeding of the mice for 2 h reduced the number of c-Fos positive cells (472 cells/ section; Po0.05). The number of c-Fos expressing neurons was also significantly lower in the arcuate nucleus of glucose-injected animals (1175 cells/section) than in fasted, saline-treated mice (Po0.05), and it did not differ significantly from that in the refed mice ( Fig. 1 ).
Blood glucose levels in ad-libitum-fed mice were 7.970.3 mmol/l when measured at the beginning of the dark phase. At the same time point 12-h-fasted mice had a significantly lower blood glucose level of 6.470.3 mmol/l (Po0.01) ( Fig. 2a ). When fasted mice were given access to chow, their blood glucose level rose significantly above that of fasted controls within 45 min of feeding, and remained elevated until the end of the blood sampling period ( Fig. 2a ). Glucose injection in fasted mice induced a more than twofold increase in blood glucose levels, reaching maximum levels at 20 min after injection (Fig. 2b ).
Discussion
The arcuate nucleus is a receptive region for numerous peripheral feeding-related signals and its activity correlates with the nutritional status. In this study, an increase in blood glucose, induced by exogenous glucose administration, reversed the fasting-induced c-Fos expression similar to the chow refeeding. To our knowledge this is the first in-vivo study to show an inhibitory effect of increased glucose levels in the arcuate nucleus.
We presume that the increase in blood glucose levels after glucose injection had a direct inhibitory effect on glucosensitive neurons. The arcuate nucleus contains two different populations of gluco-sensitive neurons that reduce their spontaneous firing rate when the ambient glucose concentration rises within a discrete range [3, 4] . According to this classification, glucose-inhibited neurons decrease firing when extracellular glucose levels increase within the range of 0.1-5 mmol/l. These glucose-inhibited neurons might primarily monitor the glucose concentration in the brain parenchyma that is protected by the blood brain barrier and where the extracellular glucose concentration does not exceed 5 mmol/l even in severe peripheral hyperglycemia [14] . Interestingly, most of the c-Fos-positive neurons in the arcuate nucleus of fasted mice express neuropeptide Y [6] and these cells are glucose-inhibited neurons [4, 15] . Hence, it is conceivable that a considerable fraction of the neurons in which c-Fos expression was reversed after glucose injection in our study are the glucoseinhibited neuropeptide Y neurons.
A distinct neuron population in the arcuate nucleus shows a similar response as the glucose-inhibited cells, but only at higher glucose levels, above 5 mmol/l. Therefore, these cells were termed high glucose-inhibited neurons and were suggested to directly monitor blood glucose levels [3, 4] . Chemicals in the blood seem to reach the axon terminals of arcuate neurons directly, through the fenestrated capillaries of the neighboring median eminence [16, 17] . Although the neurochemical or functional properties of the high glucose-inhibited neurons are unknown, they may also have been affected by increasing blood glucose levels in our studies.
Besides a direct effect of glucose on arcuate nucleus neurons, indirect mechanisms elicited by glucose administration are also likely to contribute to the inhibition of neuronal activity. Peripheral glucoreceptors in the hepatoportal system and splanchnic afferents modulate neuronal responses in hypothalamic areas after glucose application [18] . Furthermore, under physiological conditions an increase in blood glucose levels triggers, for example, insulin release. Insulin is believed to specifically inhibit orexigenic neuropeptide Y neurons [2] . The aim of our study, however, was not to distinguish between the effects of insulin and glucose on arcuate nucleus activity. Notably, under physiological postprandial conditions the neuronal effects of glucose and insulin occur in parallel and are therefore likely to act in concert in the modulation of neuronal activity.
The glucose dose used in our study induced a robust, but transient increase in blood glucose levels that exceeded the postprandial increase during chow refeeding under our experimental conditions. Nonetheless, plasma glucose levels increase to similar values (15-17 mmol/l) after a large meal [14] . Furthermore, in the glucose-injected mice, many feeding-related signals, for example, preabsorptive factors and postprandial signals, triggered mainly by other nutrients, were absent. Such signals, however, are also likely to contribute to the reversal of arcuate nucleus activation after chow refeeding and might even interact. Synergistic inhibitory effects on the fasting-induced neuronal activation in the arcuate nucleus have been reported, for example, for leptin and cholecystokinin [9] . Thus, in the refed state, that is, in the presence of different interacting anorectic factors, a relatively small postprandial increase of plasma glucose levels might have a stronger inhibitory impact than a large dose of glucose injection in the fasted state. Our results, however, suggest that an increase in blood glucose alone is capable to suppress the activity of these cells. Nevertheless, even the high dose of glucose used in our study tended to reduce arcuate nucleus activity less than refeeding, although the difference between these groups did not reach statistical significance. The contribution of other feeding-related factors to the inhibition of arcuate nucleus neurons during refeeding is therefore very likely, but remains to be verified under the current experimental conditions.
Our studies do not exclude hyperosmotic effects of the glucose injection. Equiosmolar solutions that are used to control osmotic effects of glucose in vitro, for example, mannitol, saline and urea are unlikely to represent adequate stimuli for in-vivo studies. These solutes show different pharmacokinetics, such as, different plasma clearance rates and brain transport mechanisms, and they induce different changes in plasma and cerebrospinal fluid osmolarity [19] [20] [21] . Furthermore, to our knowledge there are no published studies supporting an osmo-sensitive function of the arcuate nucleus. For this reason and because the underlying neuromechanisms are well established, the specific (direct or indirect) inhibitory effects of glucose discussed above appear more plausible.
Conclusion
We conclude that a postprandial rise in glucose levels, in concert with other feeding-related signals, is an important inhibitory factor that opposes orexigenic stimuli activating arcuate nucleus neurons. This observation strongly supports the concept that an inhibitory action of glucose on arcuate nucleus neurons is involved in the glucose-dependent inhibition of food intake. 
